Haleon and A*STAR Launch Study on Metabolic Health in Midlife Asian Women
Event summary
- Haleon and A*STAR IHDP launched the ISMOS study on August 10, 2026 to examine the impact of Centrum multivitamin supplements on metabolic health in midlife Asian women.
- The study aims to address the underrepresentation of this demographic in global nutrition research.
- Previous research by Haleon and A*STAR IHDP found that higher vitamin levels were associated with better metabolic health markers, including lower blood sugar, cholesterol, and blood pressure.
- Metabolic syndrome is a growing concern in Asia due to aging populations and busy lifestyles.
The big picture
Haleon's collaboration with A*STAR IHDP underscores the growing emphasis on preventive healthcare and healthy aging in Asia. The study addresses a critical gap in nutrition research, particularly for midlife women who face unique physiological changes and higher risks of metabolic syndrome. This initiative aligns with broader industry trends towards personalized health solutions and the economic benefits of investing in women's health.
What we're watching
- Study Outcomes
- Whether the ISMOS study will provide conclusive evidence on the role of Centrum in supporting metabolic health in midlife Asian women.
- Market Expansion
- How Haleon leverages this research to expand its product offerings and market presence in Asia.
- Regulatory Impact
- The potential influence of study results on regulatory standards for nutritional supplements targeting metabolic health.